These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21668964)

  • 1. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance.
    Leyva F; Foley PW; Chalil S; Ratib K; Smith RE; Prinzen F; Auricchio A
    J Cardiovasc Magn Reson; 2011 Jun; 13(1):29. PubMed ID: 21668964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study.
    Taylor RJ; Umar F; Panting JR; Stegemann B; Leyva F
    Heart Rhythm; 2016 Feb; 13(2):481-9. PubMed ID: 26498258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality imaging for real-time image-guided left ventricular lead placement during cardiac resynchronization therapy implantations.
    Salden OAE; van den Broek HT; van Everdingen WM; Mohamed Hoesein FAA; Velthuis BK; Doevendans PA; Cramer MJ; Tuinenburg AE; Leufkens P; van Slochteren FJ; Meine M
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1327-1337. PubMed ID: 30847659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
    Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
    Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal But Not Diffuse Myocardial Fibrosis Burden Quantification Using Cardiac Magnetic Resonance Imaging Predicts Left Ventricular Reverse Modeling Following Cardiac Resynchronization Therapy.
    Chen Z; Sohal M; Sammut E; Child N; Jackson T; Claridge S; Cooklin M; O'Neill M; Wright M; Gill J; Chiribiri A; Schaeffter T; Carr-White G; Razavi R; Rinaldi CA
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):203-9. PubMed ID: 26463874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.
    Acosta J; Fernández-Armenta J; Borràs R; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Andreu D; Soto-Iglesias D; Evertz R; Matiello M; Alonso C; Villuendas R; de Caralt TM; Perea RJ; Ortiz JT; Bosch X; Serra L; Planes X; Greiser A; Ekinci O; Lasalvia L; Mont L; Berruezo A
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):561-572. PubMed ID: 28780194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.
    Alpendurada F; Guha K; Sharma R; Ismail TF; Clifford A; Banya W; Mohiaddin RH; Pennell DJ; Cowie MR; McDonagh T; Prasad SK
    J Cardiovasc Magn Reson; 2011 Oct; 13(1):68. PubMed ID: 22040270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of cardiac resynchronization therapy using single-vein, three-pole, multipoint left ventricular pacing in patients with ischaemic cardiomyopathy and a left ventricular free wall scar: the MAESTRO study.
    Umar F; Taylor RJ; Stegemann B; Marshall H; Flannigan S; Lencioni M; De Bono J; Griffith M; Leyva F
    Europace; 2016 Aug; 18(8):1227-34. PubMed ID: 26718535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of Myocardial Contrast-Enhanced T
    Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.
    Wong TC; Piehler KM; Zareba KM; Lin K; Phrampus A; Patel A; Moon JC; Ugander M; Valeti U; Holtz JE; Fu B; Chang CC; Mathier M; Kellman P; Butler J; Gheorghiade M; Schelbert EB
    J Am Heart Assoc; 2013 Nov; 2(6):e000416. PubMed ID: 24249712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female gender is associated with a better outcome after cardiac resynchronization therapy.
    Leyva F; Foley PW; Chalil S; Irwin N; Smith RE
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):82-8. PubMed ID: 21214589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.